Abilify and Nuvaring drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Nuvaring (ethinyl estradiol; etonogestrel). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Nuvaring. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.



On Jul, 09, 2026

67 people who take Abilify and Nuvaring together, and have interactions are studied.

Abilify and Nuvaring drug interactions.

What are the common drug interactions of Abilify and Nuvaring, by gender? *:

female:

  1. Anxiety
  2. Vomiting
  3. Blood pressure increased
  4. Dizziness
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Apnoea (suspension of external breathing)
  7. Blood folate increased
  8. Blood sodium increased
  9. Carbon dioxide decreased
  10. Glomerular filtration rate decreased

male:

n/a

What are the common drug interactions of Abilify and Nuvaring, by age (0-1 to 60+)? *:

0-1:

  1. Hypotonia neonatal (low muscle tone in neonatal)
  2. Neonatal disorder (disease of neonates)
  3. Nystagmus (a condition of involuntary eye movement)
  4. Respiratory disorder neonatal (disease of respiratory organs in a month old baby)
  5. Maternal exposure during pregnancy (use of substance during pregnancy)

2-9:

n/a

10-19:

  1. Cough
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Rib fracture
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Vomiting
  6. Therapeutic response unexpected
  7. Tinnitus (a ringing in the ears)
  8. Drug ineffective
  9. Injection site pain

20-29:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Emotional disorder
  4. Insomnia (sleeplessness)
  5. Maternal exposure during pregnancy (use of substance during pregnancy)
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Nausea (feeling of having an urge to vomit)
  8. Ovarian cyst (fluid filled sac of the ovary)
  9. Pain
  10. Pain in extremity

30-39:

  1. Blood pressure increased
  2. Heart rate increased
  3. Anxiety
  4. Dizziness
  5. Gait disturbance
  6. Abdominal pain lower
  7. Arthralgia (joint pain)
  8. Back pain
  9. Dyspnoea (difficult or laboured respiration)
  10. Groin pain

40-49:

  1. Anxiety
  2. Apnoea (suspension of external breathing)
  3. Injury
  4. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  5. Loss of employment
  6. Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
  7. Myalgia (muscle pain)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Snoring
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 24 people, 35.82%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 20.90%
  3. Stress And Anxiety: 8 people, 11.94%
  4. Drowsiness: 7 people, 10.45%
  5. Labor Induction: 5 people, 7.46%
  6. Bipolar Disorder (mood disorder): 5 people, 7.46%
  7. Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 4 people, 5.97%
  8. Insomnia (sleeplessness): 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Nuvaring?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuvaring and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and ethinyl estradiol; etonogestrel (the active ingredients of Abilify and Nuvaring, respectively), and Abilify and Nuvaring (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: